The advance of adjuvant treatment for triple-negative breast cancer

Triple-negative breast cancer (TNBC) is a subtype of breast cancer characterized by its highly aggressive behavior, early recurrence, and poor outcomes, when compared with other subtypes. Due to the absence of the estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Ge, Jingyu, Zuo, Wenjia, Chen, Yiyu, Shao, Zhiming, Yu, Keda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Compuscript 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832962/
https://www.ncbi.nlm.nih.gov/pubmed/34448553
http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0752

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832962/
https://www.ncbi.nlm.nih.gov/pubmed/34448553
http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0752

Ejemplares similares